Polycythemia vera
Jump to navigation
Jump to search
![](http://s9.addthis.com/button1-share.gif)
Clinical criteria
JAK2 mutations
Mutations in the JAK2 gene, specifically at the V617F locus, give rise to myeloproliferative disorders such as essential thrombocythemia and polycythemia vera.[1]
Authors reported[2] that other mutations of the coding region of the JAK2 gene could create a polycythemia phenotype.